By Hayley Fowler (September 9, 2022, 3:43 PM EDT) -- Sebela Pharmaceuticals Inc. can't revive its lawsuit accusing TruPharma LLC of false advertising involving a lower-priced topical cream for hemorrhoids after the Third Circuit found it failed to allege how its competitor misled buyers. Calling the lower court's opinion "pithy and well-crafted," a three-judge panel on Wednesday affirmed dismissal of the suit alleging information TruPharma gave to drug databases that resulted in the competing products being listed together was false advertising. Sebela had argued TruPharma was trying to bill its product as an equivalent of Sebela's to garner sales. "The mere listing together of these products in the databases, however, is. . .
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
The author and behavioural scientist, Gad Saad, has just published a book on what he calls “suicidal empathy”. He says that “a society dies when it cares more about exhibiting infinite tolerance a...